JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective-Reference-Cited by-同舟云学术

JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective

Published:2011-09 Issue:5 Volume:25 Page:229-237
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Tefferi A.,Pardanani A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference95 articles.

1. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms;Tefferi;Leukemia,2008

2. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009

3. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment;Barosi;Leukemia,2008

4. Survival and Risk of Leukemic transformation in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study on 1,104 Patients;Barbui,2010

5. Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation;Gangat;Br J Haematol,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment;Biomedicine & Pharmacotherapy;2022-07

2. Cutaneous lupus erythematosus: The impact of self‐amplifying innate and adaptive immune responses and future prospects of targeted therapies;Experimental Dermatology;2020-08-03

3. Polycythemia vera: the current status of preclinical models and therapeutic targets;Expert Opinion on Therapeutic Targets;2020-05-18

4. Non-receptor Tyrosine Kinases Role and Significance in Hematological Malignancies;Tyrosine Kinases as Druggable Targets in Cancer;2019-09-25

5. Study on the binding mode of a pyrrolotriazin derivative with JAK2 by docking and MD simulation;Molecular Simulation;2018-12-28